FATE FY 2019 Earnings — Fate Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FATEFate Therapeutics, Inc.

$142M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11M+125.3% YoY

Gross Profit

$11M100.0% margin

Operating Income

-$101M-943.1% margin

Net Income

-$98M-919.0% margin

EPS (Diluted)

$-1.43

Cash Flow

Operating Cash Flow

-$83M

Free Cash Flow

-$91M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$302M

Total Liabilities

$58M

Stockholders' Equity

$245M

Cash & Equivalents

$100M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$5M	+125.3%
Gross Profit	$11M	-$51M	+120.8%
Operating Income	-$101M	-$67M	-50.1%
Net Income	-$98M	-$67M	-47.4%